Tebentafusp in the Treatment of Metastatic Uveal Melanoma: Patient Selection and Special Considerations

Uveal melanoma (UM) is a rare type of melanoma with distinct features from cutaneous melanoma, low response rates to immune checkpoint inhibition, and poor survival rates. Tebentafusp, a bispecific antibody engaging T cells with gp 100 on HLA-A*02:01, was recently approved by the FDA as the first dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Montazeri, Kamaneh, Pattanayak, Vikram, Sullivan, Ryan J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921510/
https://www.ncbi.nlm.nih.gov/pubmed/36785760
http://dx.doi.org/10.2147/DDDT.S368954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921510/
https://www.ncbi.nlm.nih.gov/pubmed/36785760
http://dx.doi.org/10.2147/DDDT.S368954

Ejemplares similares